Initially established in 1971, Beijing Beiwei Pharmaceuticals Co., Ltd. (BBP) is a joint stock company regrouped on the basis of Beijing Beiwei Pharmaceutical Factory, which is invested by Beijing Medical School, Beijing Wanbo Technological Development Co., Ltd. And Beijing Xiyue Health Products Co., Ltd.

BBP's business scope covers from traditional Chinese medicines, western medicines, troches (including Cephalosporins), granules (including Cephalosporins), capsules (including Cephalosporins), soft capsules, pills, pulvis, powders, syrups, mixtures, and oral liquids to tinctures. We have both full range of products and the license to export and import. A wide variety of products have gained quality awards home and abroad, such as "Qi Rong Run Chang" oral liquid is state-level new drug in 2000. BBP's yearly productive capacity is 1 billion tablets, 60 million packages of Granules, 100 million capsules, 100 million soft capsules, 60 million packages of pulvis, 30 million oral liquids and the Chinese herb plant could decoct 2 tons traditional Chinese herb. All the dosage forms have been passed national GMP audit.

BBP's strong technical team consists of technical consultant Professor Jin Shiyuan from China Association of Chinese Medicine, QA manager Mr. Cao Zhaobo from Beijing Tongrentang pharmaceutical factory etc. Licensed pharmacists and technicians upon pharmacist post title account for 26% of all. Employees from management staffs to technicians who have been occupied with pharmaceuticals for 30 years are pharmaceutical engineers and undergraduates with major in pharmacy. All the major person-in-charge of production and technology are technical backbone of Beijing Double Crane High-Tech Natural Pharmaceuticals.